Fairfield, Bush & Co. Novartis Ag Transaction History

Fairfield, Bush & Co.

  • $168 Billion
  • Q3 2024

A detailed history of Fairfield, Bush & Co. transactions in Novartis Ag stock. As of the latest transaction made, Fairfield, Bush & Co. holds 24,949 shares of NVS stock, worth $2.46 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
24,949
Previous 28,617 12.82%
Holding current value
$2.46 Million
Previous $3.05 Billion 5.81%
% of portfolio
1.71%
Previous 1.83%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $389,284 - $443,424
-3,668 Reduced 12.82%
24,949 $2.87 Billion
Q2 2024

Aug 15, 2024
SELL
$92.57 - $107.37 $17,773 - $20,615
-192 Reduced 0.67%
28,617 $3.05 Billion
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $57,447 - $65,407
-603 Reduced 2.05%
28,809 $2.79 Billion
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $362,067 - $398,442
-3,924 Reduced 11.77%
29,412 $2.97 Billion
Q3 2023

Nov 15, 2023
SELL
$94.73 - $105.13 $710,475 - $788,475
-7,500 Reduced 18.37%
33,336 $3.4 Billion
Q2 2023

Aug 15, 2023
SELL
$92.52 - $104.91 $34,695 - $39,341
-375 Reduced 0.91%
40,836 $4.12 Billion
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $597,103 - $692,455
7,461 Added 22.11%
41,211 $3.79 Billion
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $22,060 - $27,015
-292 Reduced 0.86%
33,750 $3.06 Billion
Q3 2022

Nov 07, 2022
SELL
$74.61 - $87.26 $231,514 - $270,767
-3,103 Reduced 8.35%
34,042 $2.59 Million
Q2 2022

Aug 09, 2022
SELL
$80.52 - $93.75 $360,568 - $419,812
-4,478 Reduced 10.76%
37,145 $3.14 Million
Q1 2022

May 06, 2022
BUY
$80.11 - $90.62 $4,646 - $5,255
58 Added 0.14%
41,623 $3.65 Million
Q4 2021

Feb 09, 2022
SELL
$79.7 - $88.13 $918,542 - $1.02 Million
-11,525 Reduced 21.71%
41,565 $3.64 Million
Q3 2021

Nov 08, 2021
SELL
$81.78 - $95.14 $719,991 - $837,612
-8,804 Reduced 14.22%
53,090 $4.34 Million
Q2 2021

Aug 02, 2021
SELL
$85.24 - $94.15 $265,011 - $292,712
-3,109 Reduced 4.78%
61,894 $5.65 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $50,935 - $60,066
-610 Reduced 0.93%
65,003 $5.56 Million
Q3 2020

Nov 18, 2020
SELL
$82.14 - $91.0 $3,285 - $3,640
-40 Reduced 0.06%
65,613 $5.71 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $6,393 - $7,196
-79 Reduced 0.12%
65,653 $5.73 Million
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $119,290 - $167,128
-1,688 Reduced 2.5%
65,732 $5.42 Million
Q4 2019

Feb 12, 2020
SELL
$84.35 - $95.37 $58,960 - $66,663
-699 Reduced 1.03%
67,420 $6.38 Million
Q3 2019

Nov 13, 2019
SELL
$85.54 - $94.26 $253,369 - $279,198
-2,962 Reduced 4.17%
68,119 $5.92 Million
Q2 2019

Aug 13, 2019
SELL
$75.4 - $92.8 $533,228 - $656,281
-7,072 Reduced 9.05%
71,081 $6.49 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $74,416 - $85,116
-988 Reduced 1.25%
78,153 $7.51 Million
Q4 2018

Feb 11, 2019
SELL
$73.66 - $82.02 $36,461 - $40,599
-495 Reduced 0.62%
79,141 $6.79 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $559,149 - $646,772
-8,353 Reduced 9.49%
79,636 $6.86 Million
Q2 2018

Aug 16, 2018
SELL
$64.91 - $73.36 $291,900 - $329,899
-4,497 Reduced 4.86%
87,989 $6.65 Million
Q1 2018

May 09, 2018
SELL
$70.39 - $84.15 $507,300 - $606,469
-7,207 Reduced 7.23%
92,486 $7.48 Million
Q4 2017

Feb 22, 2018
BUY
$72.33 - $77.64 $355,574 - $381,678
4,916 Added 5.19%
99,693 $8.37 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $2,594 - $2,704
-35 Reduced 0.04%
94,777 $8.14 Million
Q2 2017

Aug 15, 2017
BUY
N/A
94,812
94,812 $7.91 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fairfield, Bush & Co. Portfolio

Follow Fairfield, Bush & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email